Thierry Durand Selected Research

Glucose (Dextrose)

3/2021	Peripancreatic Adipose Tissue Remodeling and Inflammation during High Fat Intake of Palm Oils or Lard in Rats.
3/2021	Potential physio-pathological effects of branched fatty acid esters of hydroxy fatty acids.
1/2020	Long-term high intake of 9-PAHPA or 9-OAHPA increases basal metabolism and insulin sensitivity but disrupts liver homeostasis in healthy mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Thierry Durand Research Topics

Disease

31	Inflammation (Inflammations) 02/2024 - 03/2014
14	Rett Syndrome (Rett's Disorder) 04/2021 - 12/2011
9	Obesity 01/2023 - 02/2018
7	Insulin Resistance 01/2023 - 01/2018
7	Neurodevelopmental Disorders 04/2021 - 07/2012
6	Neoplasms (Cancer) 12/2023 - 11/2019
6	Breast Neoplasms (Breast Cancer) 05/2023 - 12/2015
5	Alzheimer Disease (Alzheimer's Disease) 01/2024 - 01/2018
4	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2024 - 02/2019
4	COVID-19 12/2023 - 01/2022
4	Atherosclerosis 11/2020 - 01/2014
4	Hypoxia (Hypoxemia) 01/2020 - 04/2015
3	Macular Degeneration (Age-Related Maculopathy) 12/2023 - 05/2020
3	Infections 12/2023 - 01/2019
3	Overweight 01/2023 - 01/2019
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 09/2010
3	Disease Progression 01/2020 - 12/2011
2	Neuroblastoma 01/2024 - 08/2014
2	Cardiac Arrhythmias (Arrythmia) 12/2023 - 09/2015
2	Hypersensitivity (Allergy) 01/2023 - 01/2019
2	Hypertension (High Blood Pressure) 01/2023 - 01/2022
2	Weight Gain 01/2023 - 02/2018
2	Retinal Degeneration 05/2022 - 01/2020
2	Dyslipidemias (Dyslipidemia) 01/2022 - 01/2019
2	Body Weight (Weight, Body) 01/2022 - 10/2019
2	Birth Weight (Birth Weights) 08/2021 - 10/2019
2	Myocardial Infarction 01/2021 - 01/2019
2	Reperfusion Injury 10/2019 - 01/2017
2	Brain Diseases (Brain Disorder) 07/2018 - 04/2016
2	Epilepsy (Aura) 01/2017 - 02/2015
2	Dehydration (Water Stress) 03/2016 - 04/2015
2	Autism Spectrum Disorder 01/2013 - 01/2013
2	Vascular Diseases (Vascular Disease) 10/2006 - 03/2002
1	Maternal Obesity 01/2023
1	Gestational Weight Gain 01/2023
1	Hypercholesterolemia 01/2023
1	Heart Failure 01/2023
1	Thrombosis (Thrombus) 01/2023
1	Hyperglycemia 01/2023
1	Gestational Diabetes (Gestational Diabetes Mellitus) 01/2023
1	Malnutrition (Nutritional Deficiencies) 01/2023

Drug/Important Bio-Agent (IBA)

27	Biomarkers (Surrogate Marker)IBA 02/2024 - 07/2006
23	LipidsIBA 12/2023 - 12/2011
20	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 02/2024 - 07/2012
14	OxylipinsIBA 02/2024 - 01/2016
12	Methyl-CpG-Binding Protein 2IBA 04/2021 - 12/2011
10	AntioxidantsIBA 01/2023 - 07/2006
9	Docosahexaenoic AcidsIBA 01/2023 - 09/2010
7	Fatty Acids (Saturated Fatty Acids)IBA 11/2022 - 09/2010
6	IsoprostanesIBA 01/2022 - 05/2005
6	adrenic acid (7,10,13,16-docosatetraenoic acid)IBA 01/2021 - 12/2011
5	NeuroprostanesIBA 01/2022 - 11/2011
4	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 01/2023 - 01/2014
4	protectin D1IBA 11/2019 - 04/2014
3	AcidsIBA 01/2023 - 01/2017
3	EstersIBA 01/2023 - 07/2018
3	PolyphenolsIBA 07/2022 - 01/2021
3	alpha-Linolenic Acid (Linolenic Acid)IBA 03/2022 - 12/2019
3	Glucose (Dextrose)FDA LinkGeneric 03/2021 - 01/2020
3	Eicosapentaenoic AcidIBA 01/2021 - 09/2010
3	ProstaglandinsIBA 01/2021 - 04/2015
3	Proteins (Proteins, Gene)FDA Link 01/2020 - 01/2013
3	Reactive Oxygen Species (Oxygen Radicals)IBA 11/2019 - 02/2015
3	8-epi-prostaglandin F2alphaIBA 07/2006 - 03/2002
2	AldehydesIBA 01/2024 - 11/2019
2	SolutionsIBA 05/2023 - 10/2022
2	F2-Isoprostanes (F2 Isoprostanes)IBA 01/2023 - 01/2021
2	Epoprostenol (Prostacyclin)FDA LinkGeneric 01/2023 - 01/2023
2	Oxidants (Oxidizing Agents)IBA 01/2023 - 08/2014
2	Arachidonic Acid (Vitamin F)IBA 01/2023 - 01/2021
2	5-PAHSAIBA 09/2022 - 02/2018
2	CytokinesIBA 01/2022 - 01/2015
2	S- (2- (N,N- diisopropylamino)ethyl)isothioureaIBA 01/2022 - 07/2006
2	ThromboxanesIBA 01/2021 - 01/2020
2	Interleukin-6 (Interleukin 6)IBA 01/2020 - 01/2019
2	EnzymesIBA 11/2019 - 07/2018
2	Hydroxyeicosatetraenoic Acids (HETE)IBA 01/2018 - 04/2015
1	Acrolein (Aqualin)IBA 01/2024
1	QuercetinIBA 12/2023
1	Liposomes (Liposome)IBA 12/2023
1	CarcinogensIBA 01/2023
1	Omega-6 Fatty Acids (Omega 6 Fatty Acids)IBA 01/2023
1	leukotoxinIBA 01/2023
1	Sucrose (Saccharose)IBA 01/2023
1	gamma-Aminobutyric Acid (GABA)IBA 01/2023
1	5- hydroxy- 6- (2- (1H- imidazol- 4- yl)ethylamino)cholestan- 3- olIBA 01/2023
1	27-hydroxycholesterolIBA 01/2023
1	Estrogens (Estrogen)FDA Link 01/2023
1	EmulsionsIBA 01/2023
1	Thromboxane A2 (A2, Thromboxane)IBA 01/2023
1	Aminobutyrates (Aminobutyric Acid)IBA 01/2023
1	Cholesterol Esters (Cholesteryl Esters)IBA 01/2023
1	CholesterolIBA 01/2023
1	EicosanoidsIBA 01/2023
1	Inflammation MediatorsIBA 01/2023

Therapy/Procedure

6	Therapeutics 12/2023 - 07/2012
2	Oral Administration 05/2022 - 02/2009
1	Intravenous Infusions 01/2023
1	Continuity of Patient Care 01/2023
1	Neoadjuvant Therapy 01/2023